Adial Pharmaceuticals, Inc. (ADIL) vs Biofrontera Inc. (BFRI)

A side-by-side comparison of Adial Pharmaceuticals, Inc. and Biofrontera Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADIL

Adial Pharmaceuticals, Inc.

$11M

$4.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BFRI

Biofrontera Inc.

$11M

$0.89HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADIL vs BFRI

growth of $100 · dividends reinvested · last 5y

ADIL -99.8% (-70.7%/yr)BFRI -99.0% (-60.1%/yr)BFRI compounded faster over this window

ADIL BFRI

ADIL vs BFRI: by the numbers

•ADIL is the larger company ($11M vs $11M market cap).
•Both run net losses; ADIL's is the smaller (0.00% vs -13.78% net margin).

Metrics side by side

Valuation

Metric	ADIL	BFRI
P/S ratio	N/A	0.25
P/B ratio	N/A	1.92

Profitability

Metric	ADIL	BFRI
Gross margin	0.00%	84.45%
Operating margin	0.00%	-21.94%
Net margin	0.00%	-13.78%
ROE	-37052.06%	-106.87%
ROIC	-240.64%	-32.27%

Growth (annualized)

Metric	ADIL	BFRI
Revenue CAGR (5Y)	N/A	15.55%
Total return CAGR (5Y)	-71.86%	N/A

Go deeper

Full ADIL analysis Full BFRI analysis Interactive comparison tool

Dig into the metrics

Adial Pharmaceuticals ROE Biofrontera ROE Adial Pharmaceuticals operating margin Biofrontera operating margin Adial Pharmaceuticals revenue growth Biofrontera revenue growth Adial Pharmaceuticals free cash flow Biofrontera free cash flow

Adial Pharmaceuticals & Biofrontera appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.